Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts 02134


Purpose:

The MoodNetwork, a patient-powered research network (PPRN), is one of 18 PPRNs participating in Patient-Centered Outcomes Research Institute's (PCORI) PCORnet network. Its objective is to improve the nation's capacity to conduct comparative effectiveness research that reflects questions of greatest importance to patients and other stakeholders. A robust data infrastructure will be built that, in phase one, allows participants to contribute data, including those from participant questionnaires, visualize their own health information in intuitive and helpful ways, and share their aggregated de-identified health information within and outside of the Network.


Criteria:

Inclusion Criteria: - English speaking - Valid email address - Self-identify as having a mood disorder Exclusion Criteria: - Under 18 years of age


Study is Available At:


Original ID:

2014P001346


NCT ID:

NCT02453438


Secondary ID:


Study Acronym:


Brief Title:

Mood Patient Powered Research Network (MoodNetwork)


Official Title:

Mood Patient Powered Research Network (MoodNetwork)


Overall Status:

Completed


Study Phase:

N/A


Genders:

N/A


Minimum Age:

18 Years


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Massachusetts General Hospital


Oversight Authority:

United States: Institutional Review Board


Reasons Why Stopped:


Study Type:

Observational [Patient Registry]


Study Design:


Number of Arms:

0


Number of Groups:

0


Total Enrollment:

5716


Enrollment Type:

Actual


Overall Contact Information

Official Name:Andrew A Nierenberg, M.D.
Principal Investigator
Massachusetts General Hospital

Study Dates

Start Date:March 2015
Completion Date:March 2019
Completion Type:Actual
Primary Completion Date:March 2019
Primary Completion Type:Actual
Verification Date:September 2019
Last Changed Date:September 5, 2019
First Received Date:May 5, 2015

Study Outcomes

Outcome Type:Primary Outcome
Measure:Experience of Care and Health Outcomes Questionnaire
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Depression and Bipolar Support Alliance Wellness Tracker Questionnaire
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:WHO-five well-being index (WHO-5)
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Altman Self Rated Mania Scale
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Quick Inventory of Depressive Symptoms Self Report
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Mini International Neuropsychiatric Interview Depression
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Composite International Diagnostic Interview Mania Questionnaire
Time Frame:average of 3 years
Safety Issues:False
Outcome Type:Primary Outcome
Measure:Patient Reported Outcomes Working Group Items Questionnaire
Time Frame:average of 3 years
Safety Issues:False

Study Interventions

Intervention Type:Other
Name:Patient Reported Outcomes
Description:Patient reported outcomes will be collected using a variety of questionnaires that assess mood symptoms.

Study Arms

There are no available Study Arms

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Massachusetts General Hospital

Samples and Retentions

Study Population: English speaking individuals over 18 years of age who self-identify as having a mood disorder.
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.